Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
Rebecca HasseliUlf Mueller-LadnerBimba F HoyerAndreas KrauseHanns-Martin LorenzAlexander PfeilJutta RichterMartin SchaeferTim SchmeiserAnja StrangfeldHendrik Schulze-KoopsReinhard E VollChristof SpeckerAnne Constanze RegiererPublished in: RMD open (2021)
Age was a major risk factor for hospitalisation as well as comorbidities such as CVD, ILD/COPD, chronic kidney disease and current or prior treatment with GCs. Moderate to high RMD disease activity was also an independent risk factor for hospitalisation, underlining the importance of continuing adequate RMD treatment during the pandemic.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- ankylosing spondylitis
- chronic kidney disease
- coronavirus disease
- sars cov
- juvenile idiopathic arthritis
- chronic obstructive pulmonary disease
- oxidative stress
- combination therapy
- end stage renal disease
- cystic fibrosis
- peritoneal dialysis